Physician profile
Maria Ramirez
NPI 1396817078
$464.86
in general payments reported to CMS, 2019-2025
11 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $166 · 2023: $62.59 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $107.28 | 2022-2025 | Airsupra |
| Pfizer INC. | $101.46 | 2025 | |
| Novartis Pharmaceuticals Corporation | $76.13 | 2022 | |
| Abbvie INC. | $40.67 | 2023 | |
| Acadia Pharmaceuticals INC | $35.36 | 2025 | Daybue |
| Inspire Medical Systems, INC. | $21.92 | 2023 | Inspire |
| Sanofi Pasteur INC. | $19.79 | 2025 | |
| Cranial Technologies, INC | $18.95 | 2025 | Doc Band |
| Novo Nordisk INC | $15.93 | 2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $13.71 | 2025 | |
| Merck Sharp & Dohme LLC | $13.66 | 2025 | Enflonsia, Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.